The sympathetic nervous system in essential hypertension

Area of Science:

• Cardiovascular Physiology
• Nephrology
• Endocrinology

Background:

• Enhanced sympathetic nervous system (SNS) activity is implicated in essential hypertension (EH).
• Previous research indicates varied findings regarding norepinephrine (NE) levels in EH patients.
• Understanding SNS contributions is crucial for managing hypertension.

Purpose of the Study:

• To investigate the role of sympathetic nervous system activity in essential hypertension.
• To analyze markers of SNS function, including catecholamine levels and baroreceptor responses.
• To elucidate the mechanisms linking SNS to hypertension development and maintenance.

Main Methods:

• Measurement of plasma norepinephrine (NE) and epinephrine (E) levels.
• Assessment of renal NE spillover and 24-hour NE levels.
• Evaluation of depressor responses to SNS blocking agents like clonidine.
• Analysis of baroreflex sensitivity and vascular reactivity to NE.
• Examination of dopamine (DA) excretion patterns.

Main Results:

• A subset of younger EH patients exhibits elevated plasma NE, increased renal NE spillover, and higher 24-hour NE levels.
• EH patients show exaggerated NE responses to stress, exercise, and tilt table tests.
• Diminished baroreceptor control is observed early in EH development.
• Elevated plasma E during stress is linked to sodium retention and enhanced vascular reactivity.
• Reduced urinary-free DA responses suggest impaired natriuretic mechanisms in EH.

Conclusions:

• SNS overactivity, characterized by increased NE outflow and impaired baroreceptor function, contributes significantly to EH.
• Epinephrine may act as a cotransmitter, facilitating NE release and vasoconstriction.
• Deficiencies in dopamine-modulated natriuretic mechanisms may play a role in EH pathogenesis.